C4X Discovery announced a license deal with Astra-Zeneca to develop an oral therapy for inflammatory and respiratory diseases. The deal includes an initial $2 million, pre-clinical milestones of up to $16 million, and potential clinical and commercial milestones of up to $420 million, plus royalties.
The weekly podcast series highlights takeaways from the Market Musings series and covers financial developments and equity performance. Episodes are recorded on Wednesdays from 12:30 to 13:00 GMT.
Investment Team members receive access to resources and research from corporate partners, can enter stock pitch competitions, and can apply to a BIF mentoring scheme starting in early November. Analysts also develop sector and technical expertise.
The Bristol Investment Fund has eight teams covering sectors of the equities market. Teams of three to five analysts, led by portfolio managers, generate ideas and research investment opportunities in their sectors.
At BIF, all members have the opportunity to attend weekly sessions where they work on stock pitch building, including valuation methods, investment theses and catalysts.
At BIF, all members have the opportunity to attend weekly sessions where they work on stock pitch building, including valuation methods, investment theses and catalysts.
